CURIS, INC. (CRIS) Current Ratio
- Current ratio · latest quarter: Value 0.49×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.49× | Current assets / current liabilities. $6.72M ÷ $13.68M ≈ 0.49× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 6.72M USD | Assets, Current |
| Current obligations | 13.68M USD | Liabilities, Current |
| Cash and equivalents | 5.07M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 5.39M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.72M | $13.68M | $5.07M | (m) | (m) | (m) | $5.39M | (m) | 0.49× |
| 2026-03-31 | $16.61M | $14.97M | $15.00M | (m) | (m) | (m) | $6.74M | (m) | 1.11× |
| 2025-12-31 | $6.92M | $14.08M | $5.06M | (m) | (m) | (m) | $5.61M | (m) | 0.49× |
| 2025-09-30 | $13.91M | $19.91M | $9.05M | (m) | $3.24M | (m) | $4.45M | $6.95M | 0.70× |
| 2025-06-30 | $14.42M | $19.37M | $10.14M | (m) | $2.75M | (m) | $4.10M | $7.35M | 0.74× |
| 2025-03-31 | $24.81M | $20.12M | $20.28M | (m) | $2.31M | (m) | $5.10M | $7.23M | 1.23× |
| 2024-12-31 | $26.39M | $19.03M | $20.00M | (m) | $3.35M | (m) | $3.02M | $7.56M | 1.39× |
| 2024-09-30 | $26.94M | $22.03M | $20.85M | $0.00 | $2.98M | (m) | $3.82M | (m) | 1.22× |
| 2024-06-30 | $34.52M | $19.37M | $10.00M | $18.36M | $2.55M | (m) | $2.45M | (m) | 1.78× |
| 2024-03-31 | $46.07M | $11.30M | $29.96M | $10.76M | $2.15M | (m) | $3.63M | (m) | 4.08× |
| 2023-12-31 | $60.91M | $22.02M | $26.68M | $29.65M | $2.79M | (m) | $3.17M | $8.50M | 2.77× |
| 2023-09-30 | $73.43M | $13.71M | $24.47M | $44.03M | $2.85M | (m) | $5.22M | (m) | 5.36× |
| 2023-06-30 | $67.85M | $9.68M | $19.82M | $43.66M | $2.39M | (m) | $2.69M | (m) | 7.01× |
| 2023-03-31 | $78.01M | $8.07M | $31.70M | $40.06M | $2.31M | (m) | $2.64M | (m) | 9.67× |
| 2022-12-31 | $92.12M | $10.01M | $19.66M | $65.97M | $2.98M | (m) | $3.19M | (m) | 9.20× |
| 2022-09-30 | $105.72M | $13.74M | $29.85M | $68.84M | $2.89M | (m) | $5.76M | (m) | 7.69× |
| 2022-06-30 | $113.40M | $12.15M | $34.01M | $73.19M | $2.40M | (m) | $5.51M | (m) | 9.33× |
| 2022-03-31 | $126.14M | $9.69M | $18.47M | $102.19M | $2.06M | (m) | $4.28M | (m) | 13.02× |
| 2021-12-31 | $122.38M | $13.44M | $40.01M | $75.87M | $3.22M | (m) | $6.42M | (m) | 9.11× |
| 2021-09-30 | $134.95M | $9.47M | $53.02M | (m) | $2.96M | (m) | $3.51M | $0.00 | 14.25× |
| 2021-06-30 | $156.53M | $7.87M | $75.03M | (m) | $2.38M | (m) | $4.05M | $0.00 | 19.90× |
| 2021-03-31 | $161.86M | $6.99M | $111.03M | (m) | $2.18M | (m) | $3.43M | $891.00K | 23.15× |
| 2020-12-31 | $172.75M | $10.08M | $129.61M | $38.88M | $3.04M | (m) | $4.17M | $557.00K | 17.14× |
| 2020-09-30 | $28.30M | $9.12M | $23.55M | $0.00 | $2.74M | (m) | $4.32M | $222.00K | 3.10× |
| 2020-06-30 | $27.26M | $9.35M | $23.62M | $153.00K | $2.49M | (m) | $4.96M | $445.00K | 2.92× |
| 2020-03-31 | $16.51M | $5.99M | $12.53M | $153.00K | $2.51M | (m) | $4.27M | (m) | 2.76× |
| 2019-12-31 | $25.00M | $6.54M | $15.43M | $5.11M | $3.24M | (m) | $4.46M | $0.00 | 3.82× |
| 2019-09-30 | $32.68M | $4.72M | $21.36M | $6.65M | $2.90M | (m) | $2.48M | $0.00 | 6.93× |
| 2019-06-30 | $38.42M | $4.38M | $27.22M | $8.10M | $2.13M | (m) | $2.16M | $0.00 | 8.77× |
| 2019-03-31 | $45.42M | $4.63M | $42.77M | $30.00K | $1.79M | (m) | $2.33M | $0.00 | 9.81× |
| 2018-12-31 | $27.96M | $13.25M | $23.64M | $634.00K | $2.86M | (m) | $2.91M | $6.88M | 2.11× |
| 2018-09-30 | $34.81M | $13.23M | $25.56M | $5.27M | $2.85M | (m) | $3.01M | $6.92M | 2.63× |
| 2018-06-30 | $43.70M | $14.50M | $30.46M | $9.96M | $2.50M | (m) | $4.28M | $6.96M | 3.01× |
| 2018-03-31 | $51.85M | $14.39M | $24.74M | $23.72M | $2.49M | (m) | $5.12M | $7.29M | 3.60× |
| 2017-12-31 | $64.29M | $14.10M | $38.29M | $21.94M | $3.07M | (m) | $5.42M | $5.89M | 4.56× |
| 2017-09-30 | $73.00M | $14.16M | $49.84M | $19.39M | $2.46M | (m) | $6.52M | $5.12M | 5.15× |
| 2017-06-30 | $54.38M | $14.61M | $26.68M | $24.36M | $2.23M | (m) | $8.20M | $3.93M | 3.72× |
| 2017-03-31 | $64.37M | $10.98M | $42.42M | $18.39M | $2.19M | (m) | $5.91M | $3.50M | 5.86× |
| 2016-12-31 | $48.20M | $13.55M | $26.04M | $18.45M | $2.46M | (m) | $5.88M | $4.94M | 3.56× |
| 2016-09-30 | $56.65M | $12.48M | $20.67M | $32.68M | $1.86M | (m) | $5.06M | $5.10M | 4.54× |
| 2016-06-30 | $64.52M | $11.32M | $8.64M | $53.03M | $1.87M | (m) | $3.88M | $5.43M | 5.70× |
| 2016-03-31 | $75.80M | $11.94M | $14.69M | $58.43M | $1.75M | (m) | $4.87M | $5.55M | 6.35× |
| 2015-12-31 | $85.50M | $10.76M | $33.09M | $49.10M | $2.11M | (m) | $4.22M | $4.61M | 7.95× |
| 2015-09-30 | $96.61M | $9.30M | $28.66M | $64.81M | $2.32M | (m) | $2.57M | $4.86M | 10.38× |
| 2015-06-30 | $102.06M | $9.05M | $31.49M | $67.70M | $2.09M | (m) | $2.39M | $4.85M | 11.28× |
| 2015-03-31 | $102.55M | $9.73M | $23.47M | $76.49M | $1.77M | (m) | $2.78M | $5.58M | 10.54× |
| 2014-12-31 | $52.21M | $10.07M | $7.75M | $42.00M | $1.96M | (m) | $2.35M | $5.71M | 5.19× |
| 2014-09-30 | $57.11M | $9.83M | $7.93M | $46.67M | $1.84M | (m) | $2.37M | $5.52M | 5.81× |
| 2014-06-30 | $60.99M | $9.93M | $10.16M | $45.61M | $4.84M | (m) | $2.85M | $5.50M | 6.14× |
| 2014-03-31 | $59.65M | $7.81M | $7.91M | $49.86M | $1.37M | (m) | $2.55M | $3.39M | 7.64× |
| 2013-12-31 | $60.17M | $6.56M | $9.59M | $48.59M | $1.48M | (m) | $2.04M | $2.61M | 9.17× |
| 2013-09-30 | $64.89M | $5.72M | $13.78M | $49.44M | $1.16M | (m) | $2.29M | $1.45M | 11.35× |
| 2013-06-30 | $58.42M | $5.37M | $9.74M | $47.39M | $863.19K | (m) | $2.58M | $1.37M | 10.89× |
| 2013-03-31 | $51.68M | $3.63M | $9.72M | $40.78M | $764.43K | (m) | $2.17M | $314.03K | 14.23× |
| 2012-12-31 | $56.85M | $3.98M | $12.75M | $42.79M | $908.06K | (m) | $2.50M | (m) | 14.29× |
| 2012-09-30 | $42.18M | $3.98M | $7.81M | (m) | $548.39K | (m) | $2.69M | (m) | 10.59× |
| 2012-06-30 | $45.42M | $3.49M | $12.09M | $32.62M | $318.31K | (m) | $2.43M | (m) | 13.01× |
| 2012-03-31 | $45.73M | $3.77M | $14.69M | $30.35M | $339.80K | (m) | $2.64M | (m) | 12.14× |
| 2011-12-31 | $38.50M | $3.79M | $15.12M | $22.60M | $42.07K | (m) | $2.36M | (m) | 10.17× |
| 2011-09-30 | $29.17M | $3.48M | $11.88M | $16.47M | $137.31K | (m) | $2.33M | (m) | 8.38× |
| 2011-06-30 | $33.30M | $3.39M | $6.79M | $25.93M | $99.52K | (m) | $2.69M | (m) | 9.83× |
| 2010-12-31 | $41.08M | $3.48M | $7.83M | $32.55M | $92.37K | (m) | $2.62M | (m) | 11.82× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |